NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported that its third-quarter revenues increased 24 percent year over year, or 16 percent organically, with strong growth for its LabChip, imaging, and research products.
The Hopkinton, Mass.-based firm brought in total revenues of $36.9 million for the three-month period ended Sept. 30, compared to $29.7 million for the third quarter of 2010. It beat the Wall Street consensus estimate of $35.6 million.